BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17052329)

  • 1. Management of high-risk patients with hypertension and left ventricular hypertrophy in Germany: differences between cardiac specialists in the inpatient and outpatient setting.
    Völler H; Sonntag FJ; Thiery J; Wegscheider K; Luft FC; Bestehorn K
    BMC Public Health; 2006 Oct; 6():256. PubMed ID: 17052329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV; Redón J; Cea-Calvo L; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J
    Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of outpatient and inpatient spine surgery patients with regards to obesity, comorbidities and readmission for infection.
    Walid MS; Robinson JS; Robinson ER; Brannick BB; Ajjan M; Robinson JS
    J Clin Neurosci; 2010 Dec; 17(12):1497-8. PubMed ID: 20800491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of a programme for structured outpatient follow-up care after inpatient rehabilitation of obese children and adolescents--a multicentre, randomized study].
    van Egmond-Fröhlich A; Bräuer W; Goldschmidt H; Hoff-Emden H; Oepen J; Zimmermann E
    Rehabilitation (Stuttg); 2006 Feb; 45(1):40-51. PubMed ID: 16468112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
    Saadeh AM; Jones JV
    J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart failure in outpatients: comorbidities and management by different specialists. The EPISERVE Study].
    González-Juanatey JR; Alegría Ezquerra E; Bertoméu Martínez V; Conthe Gutiérrez P; de Santiago Nocito A; Zsolt Fradera I
    Rev Esp Cardiol; 2008 Jun; 61(6):611-9. PubMed ID: 18570782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
    Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Inge PJ; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circulation; 2010 Aug; 122(6):585-96. PubMed ID: 20660805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension.
    Brown DW; Giles WH; Croft JB
    Am Heart J; 2000 Dec; 140(6):848-56. PubMed ID: 11099987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
    Yancy CW; Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am Heart J; 2009 Apr; 157(4):754-62.e2. PubMed ID: 19332206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy is present in one-half of newly-diagnosed peripheral arterial disease patients.
    Wright GA; Ang DS; Stonebridge PA; Belch JJ; Struthers AD
    J Hypertens; 2007 Feb; 25(2):463-9. PubMed ID: 17211255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary trends in cardiac rehabilitation in Germany: patient characteristics, drug treatment, and risk-factor management from 2000 to 2005.
    Bestehorn K; Wegscheider K; Völler H
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):312-8. PubMed ID: 18525386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
    Kartal O; Inal V; Baysan O; Sağlam K
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in hypertension control and left ventricular hypertrophy over three years.
    Cuspidi C; Michey I; Meani S; Severgnini B; Fusi V; Salerno M; Valerio C; Magrini F; Zanchetti A
    Ital Heart J; 2002 Sep; 3(9):514-9. PubMed ID: 12407847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.